Holding(s) in Company | RNS | Ticker

Holding(s) in Company

RNS Announcement

RNS Number : 4959Q

Hikma Pharmaceuticals Plc

29 February 2016

For filings with the FCA include the annex
For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESⁱ

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ⁱⁱ		Hikma Pharmaceuticals PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights			ü
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: ⁱⁱⁱ	Boehringer Ingelheim Corporation; Boehringer Ingelheim USA Corporation; Boehringer Ingelheim Auslandsbeteiligungs GmbH; Boehringer Ingelheim International GmbH; Boehringer Ingelheim Verwaltungs GmbH; Dr. Karl Thomae GmbH; C.H. Boehringer Sohn AG & Co. KG
4. Full name of shareholder(s) (if different from 3.):^iv	Boehringer Ingelheim Corporation
5. Date of the transaction and date on which the threshold is crossed or reached: ^v	29 February 2016
6. Date on which issuer notified:	29 February 2016
7. Threshold(s) that is/are crossed or reached: ^{vi, vii}	16%

8. Notified details:

A: Voting rights attached to shares ^{viii, ix}

Class/type of
shares

if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of voting rights ^x

Indirect

Direct ^xi

Indirect ^xii

Direct

Indirect

GB00B0LCW083

40,000,000

16.67%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date ^xiii

Exercise/
Conversion Period ^xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ^{xv, xvi}

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date ^xvii

Exercise/
Conversion period ^xviii

Number of voting rights instrument refers to

% of voting rights ^{xix, xx}

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

40,000,000

16.67%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: ^xxi

Boehringer Ingelheim Corporation has the following parent undertakings:

Boehringer Ingelheim USA Corporation, a Delaware corporation (wholly owns the voting shares in Boehringer Ingelheim Corporation).

Boehringer Ingelheim Auslandsbeteiligungs GmbH, a German company with limited liability (wholly owns Boehringer Ingelheim USA Corporation).

Boehringer Ingelheim International GmbH, a German company with limited liability (wholly owns Boehringer Ingelheim Auslandsbeteiligungs GmbH).

Boehringer Ingelheim Verwaltungs GmbH, a German company with limited liability (wholly owns Boehringer Ingelheim International GmbH).

Dr. Karl Thomae GmbH, a German company with limited liability (wholly owns Boehringer Ingelheim Verwaltungs GmbH).

C.H. Boehringer Sohn AG & Co. KG, a German limited partnership (wholly owns Dr. Karl Thomae GmbH).

Proxy Voting:

10. Name of the proxy holder:

N/A

11. Number of voting rights proxy holder will acquire:

12. Date on which proxy holder will acquire voting rights:

13. Additional information:

None

14. Contact name:

Stephan Bach (Corporate Treasury)

Eric Humbert (Corporate Treasury)

15. Contact telephone number:

Stephan Bach: +49 (6132) 77-3032
Eric Humbert: +49 (6132) 77-90717

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLUKVORNWAUUAR

RNS metadata

Title: Holding(s) in Company
Time: 13:59:36
Date: 29 Feb 2016
Category: Holding(s) in company
ID: 4959Q